Why the study?
Does benznidazole reduce T. cruzi antigens in heart interstitial dendritic cells and myocardial inflammation in T. cruzi-infected mice?
Does benznidazole reduce T. cruzi antigens in heart interstitial dendritic cells and myocardial inflammation in T. cruzi-infected mice?
In a murine model of Chagas disease, benznidazole treatment reduces parasite antigens in heart interstitial dendritic cells, which correlates with a decrease in chronic myocarditis.
Answers are grounded in this paper and cite their sources.
Reduces myocardial antigens and inflammation in infected mice; leaves open translation to human Chagas disease.
We investigated whether sequestered Trypanosoma cruzi antigens found in heart interstitial dendritic cells (IDCs) contribute to the residual myocarditis found in mice following treatment with benznidazole, a specific chemotherapeutic drug. IDCs are antigen-presenting cells that are MHC-II-receptor dependent. Swiss mice were divided into two experimental groups: the 1st group was infected with the Colombian strain of T. cruzi, which is resistant to treatment with benznidazole, and the 2nd group was infected with clone 21SF-C 3, which has a medium susceptibility to the drug. Treatment of the Colombian strain group started on the 120th day post-infection and for the 21SF-C3 strain group treatment was started on the 90th day. In both groups, treatment lasted for 90 days. The animals were sacrificed either 150 or 200 days post-treatment. The myocardium was analysed by immunohistochemistry using anti-MAC3, 33D1, CD11b and CD11c monoclonal antibodies for IDCs or anti-T. cruzi purified antibodies. Parasite antigens were expressed on the IDC membranes in both treated and untreated mice. Myocarditis subsided following treatment, evidenced by both histological and morphometrical evaluation. A reduction in the number of IDCs carrying T. cruzi antigens in the treated group indicates that the elimination of parasites influences antigen presentation with concomitant decreases in inflammation. There is a correlation between the presence of T. cruzi antigens in these cells and the chronic focal, residual myocarditis seen in treated mice.
No takes yet. Share an insight, caveat, or question.
Portella et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: